Vasculitis
David Jayne, MD
University of Cambridge
Cambridge, United Kingdom
Disclosure(s): AstraZeneca: Consultant (Ongoing); Aurinia: Officer or Board Member (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Chinook: Consultant (Ongoing); CSL Vifor: Consultant (Ongoing); Roche: Consultant (Ongoing)
Matthew Koster, MD, RhMSUS
Mayo Clinic
Rochester, MN, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
This session will discuss the diagnostic approach, management, and disease outcomes in adults with IgA vasculitis, focusing on differences between IgA vasculitis and IgA nephropathy.
Speaker: Matthew Koster, MD, RhMSUS – Mayo Clinic
Speaker: David R W Jayne, MD – University of Cambridge